AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kieny, M. P.
Right arrow Articles by Girard, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kieny, M. P.
Right arrow Articles by Girard, M.
Related Collections
Right arrow HIV/AIDS
Right arrow Immunization/Vaccines
Right arrow Other Infections
November 2004, Vol 94, No. 11 | American Journal of Public Health 1931-1935
© 2004 American Public Health Association

GLOBAL ALLIANCES FOR VACCINES

Research and Development of New Vaccines Against Infectious Diseases

Marie Paule Kieny, PhD, Jean-Louis Excler, MD and Marc Girard, DVM

Marie Paule Kieny is with the World Health Organization, Geneva, Switzerland. Jean-Louis Excler is with the International AIDS Vaccine Initiative, Delhi, India. At the time of this study, Marc Girard was with the Foundation Biomérieux, Annecy, France.

Correspondence: Requests for reprints should be sent to Marie Paule Kieny, PhD, Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, CH1211-Genève 27, Switzerland (e-mail: kienym{at}who.int).

Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical.

The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association